Exhibit 99.2
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)
Three Months Ended December 31, | Years Ended December 31, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Revenue | $ | 146,277 | $ | 132,738 | $ | 515,293 | $ | 469,866 | ||||||||
Cost of operations | 57,763 | 55,352 | 209,740 | 216,361 | ||||||||||||
Sales and marketing | 33,081 | 32,598 | 127,997 | 127,659 | ||||||||||||
General and administrative | 22,715 | 23,767 | 93,220 | 97,618 | ||||||||||||
Depreciation and amortization | 6,566 | 8,248 | 26,606 | 28,399 | ||||||||||||
Interest income | 22 | 22 | 76 | 86 | ||||||||||||
Interest expense | 5,329 | 5,834 | 22,826 | 23,334 | ||||||||||||
Loss on convertible notes | 1,575 | — | 4,871 | — | ||||||||||||
Gain on investments | — | — | — | 8,074 | ||||||||||||
Restructuring | — | 7,579 | — | 7,579 | ||||||||||||
Other expense | — | — | 1,353 | 2,297 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income (loss) from continuing operations before income tax provision (benefit) | 19,270 | (618 | ) | 28,756 | (25,221 | ) | ||||||||||
Income tax provision (benefit) | 8,458 | 5,470 | 13,640 | (2,134 | ) | |||||||||||
|
|
|
|
|
|
|
| |||||||||
Income (loss) from continuing operations | 10,812 | (6,088 | ) | 15,116 | (23,087 | ) | ||||||||||
Income from discontinued operations, net of tax | — | — | — | 2,743 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | $ | 10,812 | $ | (6,088 | ) | $ | 15,116 | $ | (20,344 | ) | ||||||
|
|
|
|
|
|
|
| |||||||||
Basic income (loss) per common share: | ||||||||||||||||
Income (loss) from continuing operations | $ | 0.27 | $ | (0.12 | ) | $ | 0.32 | $ | (0.45 | ) | ||||||
Income from discontinued operations | — | — | — | 0.05 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | $ | 0.27 | $ | (0.12 | ) | $ | 0.32 | $ | (0.40 | ) | ||||||
|
|
|
|
|
|
|
| |||||||||
Diluted income (loss) per common share (a): | ||||||||||||||||
Income (loss) from continuing operations | $ | 0.25 | $ | (0.12 | ) | $ | 0.31 | $ | (0.45 | ) | ||||||
Income from discontinued operations | — | — | — | 0.05 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | $ | 0.25 | $ | (0.12 | ) | $ | 0.31 | $ | (0.40 | ) | ||||||
|
|
|
|
|
|
|
| |||||||||
Weighted-average shares outstanding used in computing income (loss) per common share: | ||||||||||||||||
Basic | 40,457 | 49,041 | 46,830 | 50,862 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Diluted | 44,872 | 49,041 | 48,398 | 50,862 | ||||||||||||
|
|
|
|
|
|
|
|
(a) | See schedule of Net Income (Loss) Per Common Share below. |
WEBMD HEALTH CORP.
CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION
(In thousands, unaudited)
Three Months Ended December 31, | Years Ended December 31, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Revenue | ||||||||||||||||
Public portal advertising and sponsorship | $ | 124,353 | $ | 112,257 | $ | 433,182 | $ | 391,339 | ||||||||
Private portal services | 21,924 | 20,481 | 82,111 | 78,527 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
$ | 146,277 | $ | 132,738 | $ | 515,293 | $ | 469,866 | |||||||||
|
|
|
|
|
|
|
| |||||||||
Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”) (a) | $ | 40,636 | $ | 30,049 | $ | 122,886 | $ | 73,149 | ||||||||
Interest, taxes, non-cash and other items (b) | ||||||||||||||||
Interest income | 22 | 22 | 76 | 86 | ||||||||||||
Interest expense | (5,329 | ) | (5,834 | ) | (22,826 | ) | (23,334 | ) | ||||||||
Income tax (provision) benefit | (8,458 | ) | (5,470 | ) | (13,640 | ) | 2,134 | |||||||||
Depreciation and amortization | (6,566 | ) | (8,248 | ) | (26,606 | ) | (28,399 | ) | ||||||||
Non-cash stock-based compensation | (7,918 | ) | (9,028 | ) | (38,550 | ) | (44,921 | ) | ||||||||
Loss on convertible notes | (1,575 | ) | — | (4,871 | ) | — | ||||||||||
Gain on investments | — | — | — | 8,074 | ||||||||||||
Restructuring | — | (7,579 | ) | — | (7,579 | ) | ||||||||||
Other expense | — | — | (1,353 | ) | (2,297 | ) | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Income (loss) from continuing operations | 10,812 | (6,088 | ) | 15,116 | (23,087 | ) | ||||||||||
Income from discontinued operations, net of tax | — | — | — | 2,743 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | $ | 10,812 | $ | (6,088 | ) | $ | 15,116 | $ | (20,344 | ) | ||||||
|
|
|
|
|
|
|
|
(a) | See Annex A-Explanation of Non-GAAP Financial Measures. |
(b) | Reconciliation of Adjusted EBITDA to net income (loss). |
WEBMD HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)
December 31, | ||||||||
2013 | 2012 | |||||||
Assets | ||||||||
Cash and cash equivalents | $ | 824,880 | $ | 991,835 | ||||
Accounts receivable, net | 124,232 | 106,622 | ||||||
Prepaid expenses and other current assets | 13,243 | 13,882 | ||||||
Deferred tax assets | 13,620 | 10,328 | ||||||
|
|
|
| |||||
Total current assets | 975,975 | 1,122,667 | ||||||
Property and equipment, net | 64,884 | 66,604 | ||||||
Goodwill | 202,980 | 202,104 | ||||||
Intangible assets, net | 13,834 | 16,105 | ||||||
Deferred tax assets | 38,802 | 56,039 | ||||||
Other assets | 29,153 | 27,106 | ||||||
|
|
|
| |||||
Total Assets | $ | 1,325,628 | $ | 1,490,625 | ||||
|
|
|
| |||||
Liabilities and Stockholders’ Equity | ||||||||
Accrued expenses | $ | 73,739 | $ | 64,256 | ||||
Deferred revenue | 85,148 | 92,176 | ||||||
Liabilities of discontinued operations | 1,506 | 1,506 | ||||||
|
|
|
| |||||
Total current liabilities | 160,393 | 157,938 | ||||||
2.25% convertible notes due 2016 | 252,232 | 400,000 | ||||||
2.50% convertible notes due 2018 | 400,000 | 400,000 | ||||||
1.50% convertible notes due 2020 | 300,000 | — | ||||||
Other long-term liabilities | 22,103 | 22,698 | ||||||
Stockholders’ equity | 190,900 | 509,989 | ||||||
|
|
|
| |||||
Total Liabilities and Stockholders’ Equity | $ | 1,325,628 | $ | 1,490,625 | ||||
|
|
|
|
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
Years Ended December 31, | ||||||||
2013 | 2012 | |||||||
Cash flows from operating activities: | ||||||||
Net income (loss) | $ | 15,116 | $ | (20,344 | ) | |||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
Income from discontinued operations, net of tax | — | (2,743 | ) | |||||
Depreciation and amortization | 26,606 | 28,399 | ||||||
Non-cash interest, net | 4,192 | 4,326 | ||||||
Non-cash stock-based compensation | 38,550 | 44,921 | ||||||
Deferred income taxes | 13,070 | (2,337 | ) | |||||
Loss on convertible notes | 4,871 | — | ||||||
Gain on investments | — | (8,074 | ) | |||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | (17,610 | ) | 14,713 | |||||
Prepaid expenses and other, net | 266 | (1,589 | ) | |||||
Accrued expenses and other long-term liabilities | 8,061 | 9,429 | ||||||
Deferred revenue | (7,028 | ) | 4,121 | |||||
|
|
|
| |||||
Net cash provided by continuing operations | 86,094 | 70,822 | ||||||
Net cash provided by discontinued operations | — | 4,324 | ||||||
|
|
|
| |||||
Net cash provided by operating activities | 86,094 | 75,146 | ||||||
Cash flows from investing activities: | ||||||||
Proceeds received from ARS option | — | 9,269 | ||||||
Purchases of property and equipment | (22,341 | ) | (35,171 | ) | ||||
Proceeds from sale of property and equipment | 1,381 | — | ||||||
|
|
|
| |||||
Net cash used in investing activities | (20,960 | ) | (25,902 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from exercise of stock options | 29,724 | 827 | ||||||
Cash used for withholding taxes due on stock-based awards | (12,526 | ) | (2,740 | ) | ||||
Net proceeds from issuance of convertible notes | 291,823 | — | ||||||
Repurchase of convertible notes | (150,354 | ) | — | |||||
Repurchase of shares through tender offers | (170,516 | ) | (150,759 | ) | ||||
Purchases of treasury stock | (220,298 | ) | (26,331 | ) | ||||
Excess tax benefit on stock-based awards | 58 | 377 | ||||||
|
|
|
| |||||
Net cash used in financing activities | (232,089 | ) | (178,626 | ) | ||||
|
|
|
| |||||
Net decrease in cash and cash equivalents | (166,955 | ) | (129,382 | ) | ||||
Cash and cash equivalents at beginning of period | 991,835 | 1,121,217 | ||||||
|
|
|
| |||||
Cash and cash equivalents at end of period | $ | 824,880 | $ | 991,835 | ||||
|
|
|
|
WEBMD HEALTH CORP.
NET INCOME (LOSS) PER COMMON SHARE
(In thousands, except per share data, unaudited)
Three Months Ended | Years Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Numerator: |
| |||||||||||||||
Income (loss) from continuing operations — Basic | $ | 10,812 | $ | (6,088 | ) | $ | 15,116 | $ | (23,087 | ) | ||||||
Interest expense on 1.50% convertible notes, net of tax | 326 | — | — | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Income (loss) from continuing operations — Diluted | $ | 11,138 | $ | (6,088 | ) | $ | 15,116 | $ | (23,087 | ) | ||||||
|
|
|
|
|
|
|
| |||||||||
Income from discontinued operations, net of tax — Basic and Diluted | $ | — | $ | — | $ | — | $ | 2,743 | ||||||||
|
|
|
|
|
|
|
| |||||||||
Denominator: | ||||||||||||||||
Weighted-average shares — Basic | 40,457 | 49,041 | 46,830 | 50,862 | ||||||||||||
Stock options and restricted stock | 2,192 | — | 1,568 | — | ||||||||||||
1.50% convertible notes | 2,223 | — | — | — | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Adjusted weighted-average shares after assumed conversions — Diluted | 44,872 | 49,041 | 48,398 | 50,862 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Basic income (loss) per common share: | ||||||||||||||||
Income (loss) from continuing operations | $ | 0.27 | $ | (0.12 | ) | $ | 0.32 | $ | (0.45 | ) | ||||||
Income from discontinued operations | — | — | — | 0.05 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | $ | 0.27 | $ | (0.12 | ) | $ | 0.32 | $ | (0.40 | ) | ||||||
|
|
|
|
|
|
|
| |||||||||
Diluted income (loss) per common share: | ||||||||||||||||
Income (loss) from continuing operations | $ | 0.25 | $ | (0.12 | ) | $ | 0.31 | $ | (0.45 | ) | ||||||
Income from discontinued operations | — | — | — | 0.05 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
Net income (loss) | $ | 0.25 | $ | (0.12 | ) | $ | 0.31 | $ | (0.40 | ) | ||||||
|
|
|
|
|
|
|
|